What Has Been The Evolution of the Molecular Modeling Market in Recent Years?
The molecular modeling market has seen considerable growth due to a variety of factors.
• In recent times, there has been a significant expansion in the size of the molecular modeling market. It is expected to increase from a value of $8.25 billion in 2024 to $9.51 billion in 2025, with a compound annual growth rate (CAGR) of 15.2%.
Historical growth in this field has primarily been driven by factors such as computational chemistry and molecular dynamics, early applications in environment and sustainability, improved visualization tools, expanded usage in protein and enzyme engineering, and advances in biomolecular modeling methodologies.
What Is the Forecasted Market Size and Growth Rate for The Molecular Modeling Market Size In The Coming Years?
The molecular modeling market is expected to maintain its strong growth trajectory in upcoming years.
• The size of the molecular modeling market is anticipated to experience a substantial surge in the coming years, reaching a staggering $17.12 billion by 2029, with a compound annual growth rate (CAGR) of 15.8%.
This anticipated increase within the forecast period can be linked to the merging of artificial intelligence (AI) and machine learning methodologies, surging demands for drug discovery and development, escalating application in material science, accuracy medicine, and individualized treatment methods, including an upsurge in the use of virtual screening. Key trends within the forecast period encompass enhancements in computational ability, AI and machine learning amalgamation, burgeoning drug discovery and development, augmentation in material science applications, with a concentration on predictive medicine.
What Factors Are Driving Growth In The Molecular Modeling Market?
The molecular modeling market is expected to grow due to the rising trend in drug development. The term refers to the process of discovering, designing, testing, and finally gaining approval for and introducing new medical treatments or pharmaceutical compounds. Molecular modeling has a fundamental role in these stages because it allows an understanding of molecular transactions and estimates the stability of protein-ligand complexes, their functionality, and the efficacy of drugs. For instance, Accessibility Standards Canada, a federal institution based in Canada, reported in June 2023 that there were 9,000 new drugs being tested in clinical trials in 2022. This represents a significant growth from the approximately 8,500 drugs tested in 2021. Hence, the uptick in drug development is a key factor propelling the expansion of the molecular modeling market.
Molecular Modeling Market Driver: Ascendancy of Personalized Medicine Bolsters The Molecular Modeling Market
What Are The Main Segments Of The Global Molecular Modeling Market?
The molecular modeling market covered in this report is segmented –
1) By Product: Software, Services
2) By Approach: Molecular Mechanics Approach, Quantum Chemistry Approach
3) By Application: Drug Development, Drug Discovery, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Research Centers And Academic Institutions, Other End Users
Subsegments:
1) By Software: Molecular Visualization Software, Molecular Dynamics Software, Quantum Chemistry Software, Docking Software, Simulation Software, Other Specialized Software
2) By Services: Consulting Services, Custom Modeling Services, Training And Support Services, Data Analysis Services, Cloud-Based Services
Pre-Book The Molecular Modeling Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Molecular Modeling Industry?
Prominent corporations in the molecular modeling market are introducing innovative technologies like molecular modeling platforms to better fulfill the requirements of current customers. A molecular modeling platform is essentially a software package that offers tools for the visualization, simulation, and examination of molecules. Take for example Cresset Group, a UK-based company specializing in drug discovery solutions, which in August 2023, unveiled Flare V7 - an advanced drug design platform. Flare V7 deftly combines the strengths of ligand and structure-centric approaches to encourage more potent small-molecule discovery. This is a significant progression in molecular modeling. The platform boasts features like ensemble docking, intensification of Quantum Mechanics (QM) and Quantitative Structure-Activity Relationship (QSAR) methodologies, and several tools to streamline Flare FEP experiment troubleshooting, dynamics trajectory analysis, and ligand structure preparation for thorough studies.
Who Are the Key Players In The Molecular Modeling Market?
Major companies operating in the molecular modeling market report are:
• Thermo Fisher Scientific Inc.
• BioNTech SE
• Dassault Systemes SE
• Bruker Corporation
• Qiagen N.V.
• Physiomics PLC
• SilcsBio LLC
• Compugen Ltd.
• Certara Inc.
• Schrödinger Inc.
• Jubilant Biosys Ltd.
• Simulations Plus Inc.
• Genedata AG
• Labvantage-Biomax GmbH
• Acellera Ltd.
• Advanced Chemistry Development Inc.
• Molsoft L.L.C.
• Nimbus Therapeutics Inc.
• Crown Bioscience Inc.
• OTAVA Ltd.
• Chemical Computing Group
• Molport SIA
• Optibrium Ltd.
• BioSolveIT GmbH
• Cyclica Inc.
• Cresset Group
• Cyrus Biotechnology Inc.
• 3D Molecular Designs LLC
• Inhibrx Inc.
• Leadscope Inc.
What Is The Most Dominant Region In The Molecular Modeling Market?
North America was the largest region in the molecular modeling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular modeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
